Athenex Inc

NASDAQ:ATNX   3:59:39 PM EDT
5.00
+0.34 (+7.41%)
Mergers / Acquisitions

Athenex To Acquire Kuur Therapeutics To Expand Cell Therapy Development With Off-The-Shelf Engineered Car-Nkt Platform

Published: 05/04/2021 21:15 GMT
Athenex Inc (ATNX) - Athenex to Acquire Kuur Therapeutics to Expand Cell Therapy Development With Off-the-shelf Engineered Car-nkt Platform.
Athenex Inc - Deal for Total Potential Consideration of $185 Million.
Athenex Inc - Under Terms of Agreement, Athenex Will Pay $70 Million Upfront to Kuur Shareholders and Certain of Its Former Employees and Directors.
Athenex - Total Potential Consideration of $185 Million, Comprising $70 Million Upfront Primarily in Athenex Stock, & $115 Million in Development Milestones.